TrialAmerican journal of respiratory and critical care medicine2022

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac.

Chris Ka Pun Mok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.